SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001144204-18-047405
Filing Date
2018-08-31
Accepted
2018-08-30 21:21:34
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2092895
2 GRAPHIC lg_ikt.jpg GRAPHIC 94594
3 GRAPHIC tv501847_chrt-table1.jpg GRAPHIC 161654
4 GRAPHIC tv501847_img-dysfunctional.jpg GRAPHIC 92824
5 GRAPHIC tv501847_chrt-table2.jpg GRAPHIC 54506
6 GRAPHIC tv501847_chrt-bar1.jpg GRAPHIC 55972
7 GRAPHIC tv501847_img-pharmacology.jpg GRAPHIC 59774
8 GRAPHIC tv501847_chrt-bar2.jpg GRAPHIC 52057
9 GRAPHIC tv501847_chrt-table3.jpg GRAPHIC 69517
10 GRAPHIC tv501847_chrt-linebar.jpg GRAPHIC 47895
11 GRAPHIC tv501847_chrt-line.jpg GRAPHIC 78130
12 GRAPHIC tv501847_chrt-table4.jpg GRAPHIC 170231
  Complete submission text file 0001144204-18-047405.txt   3377604
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02245 | Film No.: 181048369
SIC: 2836 Biological Products, (No Diagnostic Substances)